Cubist Systematic Strategies LLC Acquires 6,398 Shares of National Research Co. (NASDAQ:NRC)

Cubist Systematic Strategies LLC grew its position in National Research Co. (NASDAQ:NRC) by 40.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,287 shares of the company’s stock after purchasing an additional 6,398 shares during the period. Cubist Systematic Strategies LLC owned approximately 0.09% of National Research worth $511,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of NRC. Cardinal Capital Management lifted its holdings in shares of National Research by 63.3% in the first quarter. Cardinal Capital Management now owns 26,988 shares of the company’s stock valued at $1,072,000 after purchasing an additional 10,463 shares in the last quarter. Azzad Asset Management Inc. ADV lifted its holdings in shares of National Research by 35.9% in the first quarter. Azzad Asset Management Inc. ADV now owns 25,090 shares of the company’s stock valued at $994,000 after purchasing an additional 6,629 shares in the last quarter. Norden Group LLC bought a new stake in shares of National Research in the first quarter valued at about $5,170,000. Benjamin F. Edwards & Company Inc. raised its holdings in National Research by 860.2% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock worth $45,000 after acquiring an additional 1,015 shares in the last quarter. Finally, Principal Financial Group Inc. bought a new stake in National Research during the first quarter worth about $221,000. 47.26% of the stock is currently owned by institutional investors.

National Research Stock Performance

NRC opened at $18.86 on Friday. National Research Co. has a 52-week low of $18.70 and a 52-week high of $44.60. The firm has a market capitalization of $450.19 million, a PE ratio of 15.59 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.37 and a current ratio of 0.37. The business’s 50-day simple moving average is $21.45 and its 200 day simple moving average is $26.48.

National Research (NASDAQ:NRC) last released its earnings results on Tuesday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The business had revenue of $35.02 million for the quarter.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.48 annualized dividend and a yield of 2.55%. National Research’s payout ratio is presently 39.67%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.